Position in PFE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,183,005
+$274,870 QoQ
Shares Held
184,580
-6.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Ascent Group, LLC holds $68,984,188 across 14 Drug Manufacturers - General names. PFE ranks #5 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
68,802 | $16,817,958 | |
| 2 | LLY |
ELI LILLY & Co
|
17,302 | $15,913,856 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
62,184 | $8,666,581 | |
| 4 | ABBV |
AbbVie Inc.
|
33,359 | $7,255,246 | |
| 5 | PFE |
Pfizer Inc
This page
|
184,580 | $5,183,005 | |
| 6 | MRK |
Merck & Co., Inc.
|
37,190 | $4,473,583 | |
| 7 | AMGN |
Amgen Inc
|
7,925 | $2,788,410 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
38,067 | $2,308,762 |
All Filings in PFE
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,183,005 | 184,580 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $4,908,135 | 197,114 | Shares | Other | 2026-01-20 | |
| 2025-09-30 | $4,181,874 | 164,124 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $2,262,632 | 93,343 | Shares | Other | 2025-07-21 | |
| 2025-03-31 | $2,593,546 | 102,350 | Shares | Other | 2025-05-16 | |
| 2024-12-31 | $1,847,468 | 69,637 | Shares | Other | 2025-02-21 | |
| 2024-09-30 | $1,814,885 | 62,712 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,422,643 | 50,845 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $1,145,520 | 41,280 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,224,726 | 42,540 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,676,743 | 50,550 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,506,564 | 68,336 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,922,952 | 71,641 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $5,021,468 | 97,999 | Shares | Sole | 2023-02-17 | |
| 2022-09-30 | $4,297,450 | 98,205 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $4,932,299 | 94,074 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $4,840,080 | 93,492 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $5,533,752 | 93,713 | Shares | Sole | 2022-03-01 | |
| No filing history on record for this holder in this stock. | ||||||